Suyash Prasad, CMO and Head of R&D at Taysha Gene Therapies, Inc. (TSHA), sold 87,954 shares at $3.72 ($319K) on 2022-06-30, disclosed to the SEC on 2022-07-01.
Open-market sale of $319k TSHA by CMO and Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.81 | 12,324 | $47K | 14.7% |
| 2 | $3.72 | 13,892 | $52K | 16.2% |
| 3 | $3.72 | 13,892 | $52K | 16.2% |
| 4 | $3.53 | 23,923 | $84K | 26.5% |
| 5 | $3.53 | 23,923 | $84K | 26.5% |
| Total | $3.63 avg | 87,954 |
| $319K |
| 100% |
| Filing → |
| BOLD | SELL | 2019-05-15 | $738K | — | Filing → |
| BOLD | SELL | 2019-02-27 | $301K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $536K | — | Filing → |